Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
2.210
+0.090 (4.25%)
At close: Jun 15, 2026, 4:00 PM EDT
2.270
+0.060 (2.71%)
Pre-market: Jun 16, 2026, 4:38 AM EDT
Sintx Technologies Revenue
Sintx Technologies had revenue of $380.00K in the quarter ending March 31, 2026, with 2.98% growth. This brings the company's revenue in the last twelve months to $1.03M, down -59.95% year-over-year. In the year 2025, Sintx Technologies had annual revenue of $1.02M, down -64.74%.
Revenue (ttm)
$1.03M
Revenue Growth
-59.95%
P/S Ratio
9.28
Revenue / Employee
$32,156
Employees
32
Market Cap
9.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.02M | -1.87M | -64.74% |
| Dec 31, 2024 | 2.89M | 260.00K | 9.90% |
| Dec 31, 2023 | 2.63M | 1.07M | 68.29% |
| Dec 31, 2022 | 1.56M | 955.00K | 157.59% |
| Dec 31, 2021 | 606.00K | 12.00K | 2.02% |
| Dec 31, 2020 | 594.00K | -95.00K | -13.79% |
| Dec 31, 2019 | 689.00K | 594.00K | 625.26% |
| Dec 31, 2018 | 95.00K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 15.23M | -4.23M | -21.73% |
| Dec 31, 2015 | 19.45M | -3.31M | -14.55% |
| Dec 31, 2014 | 22.77M | 451.00K | 2.02% |
| Dec 31, 2013 | 22.31M | -751.00K | -3.26% |
| Dec 31, 2012 | 23.07M | 2.80M | 13.84% |
| Dec 31, 2011 | 20.26M | 20.17M | 21,261.62% |
| Dec 31, 2006 | 94.85K | 25.64K | 37.05% |
| Dec 31, 2005 | 69.21K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| Vivos Therapeutics | 19.57M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 3.91M |
| IceCure Medical | 3.57M |
| VolitionRx | 2.47M |
| Nexalin Technology | 275.58K |
SINT News
- 11 days ago - Sintx Technologies resumed with a Buy at Maxim - TheFly
- 12 days ago - SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 4 weeks ago - SINTX Technologies to Present at the LD Micro Invitational XVI Conference - Newsfile Corp
- 2 months ago - Sintx Technologies initiated with a Buy at H.C. Wainwright - TheFly
- 3 months ago - SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution - GlobeNewsWire
- 3 months ago - Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic - TheFly
- 3 months ago - SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - GlobeNewsWire
- 4 months ago - Sintx Technologies appoints Elmore as President - TheFly